Impact of smoked cannabis on tobacco cigarette smoking intensity and subjective effects: A placebo-controlled, double-blind, within-subjects human laboratory study.
Impact of smoked cannabis on tobacco cigarette smoking intensity and subjective effects: A placebo-controlled, double-blind, within-subjects human laboratory study.
复制标题
DOI:
10.1037/pha0000391
复制
发表时间:
2021-08
影响因子:
2.3
通讯作者:
Pickworth WB
中科院分区:
文献类型:
--
作者:
Peters EN;Herrmann ES;Smith C;Wilhelm JA;Koszowski B;Halquist M;Kosmider L;Poklis J;Roth S;Bart S;Pickworth WB
Co-users of cannabis and tobacco frequently use cannabis, then tobacco cigarettes, in a sequential pattern within an occasion, i.e., they “chase” smoked cannabis with a tobacco cigarette. The objective of this placebo-controlled, double-blind, within-subjects human laboratory study was to gather preliminary data on how smoking active vs. placebo cannabis impacts tobacco cigarette smoking behavior, craving, and subjective effects. Adult daily cannabis and tobacco co-users (N=9) were randomly assigned to two experimental visit orders (i.e., active cannabis (5.2% THC) first visit and placebo cannabis second visit, or vice versa). Participants smoked one cannabis cigarette, and approximately 30 minutes later were given a 5-minute ad libitum period to smoke one of their own brand of tobacco cigarette. As expected, boost in plasma THC levels and cannabis-related subjective effects differed between active and placebo cannabis conditions. Tobacco cigarette puff topography measures and tobacco craving did not differ between cannabis conditions, but there appeared to be between-participant heterogeneity in cumulative total puff volume. After smoking active vs. placebo cannabis, the changes in subjective effects of tobacco smoking after adjusting for pre-tobacco smoking levels were not significant. Results do not support the notion that immediate effects of smoked cannabis change the behavior of tobacco smoking. The strong overlap between cannabis and tobacco smoking may not be explained by primarily pharmacological factors, but may be driven by more nuanced and complex mechanisms involving pharmacological processes as well as learning factors.
登录
查看更多内容
影响因子:
6.7
作者:
MELLO, NK;MENDELSON, JH;KUEHNLE, JC
通讯作者:
KUEHNLE, JC
影响因子:
4.2
作者:
Cooper, Ziva D.;Haney, Margaret
通讯作者:
Haney, Margaret
DOI:
10.15585/mmwr.mm6702a1
发表时间:
2018-01-19
期刊:
MMWR. Morbidity and mortality weekly report
影响因子:
--
作者:
Jamal A;Phillips E;Gentzke AS;Homa DM;Babb SD;King BA;Neff LJ
通讯作者:
Neff LJ
影响因子:
12.7
作者:
Goodwin, Renee D.;Pacek, Lauren R.;Hasin, Deborah S.
通讯作者:
Hasin, Deborah S.
影响因子:
6.7
作者:
HENNINGFIELD, JE;CHAIT, LD;GRIFFITHS, RR
通讯作者:
GRIFFITHS, RR